Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.verified

MEDXF

Price:

$2.89

Market Cap:

$91.95M

Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, including cancer treatment (oncology), blood disorders (hematology), joint and muscle conditions (rheumatology), autoimmune disorders, and allergic reactions. Among its leading offerings are Rasuvo and Metoject, both methotrexate formulations specifically developed for managing rheumatoid arthritis and various autoimmune conditions. Another significant product is IXINITY, an intravenous recombinant factor IX therapy prescribed for individuals aged 12 and above suffering from Hemophilia B. Additionally...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-11-27

Stock Exchange

OTC

Ticker

MEDXF

The PE Ratio as of June 2026 (TTM) for Medexus Pharmaceuticals Inc. (MEDXF) is -144.50

According to Medexus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -144.50. This represents a change of -331.60% compared to the average of 62.39 of the last 4 quarters.

Medexus Pharmaceuticals Inc. (MEDXF) Historical PE Ratio (quarterly & annually)

How has MEDXF PE Ratio performed in the past?

The mean historical PE Ratio of Medexus Pharmaceuticals Inc. over the last ten years is -18.41. The current -144.50 PE Ratio has changed 78.37% with respect to the historical average. Over the past ten years (40 quarters), MEDXF's PE Ratio was at its highest in in the December 2025 quarter at 294.90. The PE Ratio was at its lowest in in the September 2025 quarter at -66.63.

Quarterly (TTM)
Annual

Average

-18.41

Median

-7.67

Minimum

-167.93

Maximum

27.81

Medexus Pharmaceuticals Inc. (MEDXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medexus Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 399.50%

Maximum Annual PE Ratio = 27.81

Minimum Annual Increase = -741.53%

Minimum Annual PE Ratio = -167.93

Quarterly (TTM)
Annual
YearPE RatioChange
202527.81-116.56%
2024-167.93-741.53%
202326.18-223.37%
2022-21.22399.50%
2021-4.25-44.38%
2020-7.64-14.44%
2019-8.9315.90%
2018-7.70-47.98%
2017-14.81161.28%
2016-5.67-8.80%

Medexus Pharmaceuticals Inc. (MEDXF) Average PE Ratio

How has MEDXF PE Ratio performed in the past?

The current PE Ratio of Medexus Pharmaceuticals Inc. (MEDXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-37.98

5-year avg

-27.88

10-year avg

-18.41

Medexus Pharmaceuticals Inc. (MEDXF) PE Ratio vs. Peers

How is MEDXF’s PE Ratio compared to its peers?

Medexus Pharmaceuticals Inc.’s PE Ratio is less than Planet 13 Holdings Inc. (-0.59), less than Decibel Cannabis Company Inc. (-22.54), less than Earth Science Tech, Inc. (14.25), less than Flower One Holdings Inc. (-0.03), less than TransCanna Holdings Inc. (-0.04), less than Precision System Science Co., Ltd. (39.55), less than 1CM Inc. (3.68), less than Radnostix, Inc. (-0.00), less than Vext Science, Inc. (-2.89), less than Nicox S.A. (-13.33),

Build a custom stock screener for Medexus Pharmaceuticals Inc. (MEDXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medexus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medexus Pharmaceuticals Inc. (MEDXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medexus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medexus Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the highest PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 3-year average PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 5-year average PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

How does the current PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF) compare to its historical average?